Aspartic Acid

Aspartic Acid

SCHEMBL379367

C[N+](C)(C)CC(=O)O.N[C@@H](CC(=O)[O-])C(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3SSTR1SSTR2SSTR3SSTR5

The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.52
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
APEX1 P27695 1/20 0.50
CPT2 P23786 1/20 0.48
CPT1A P50416 1/20 0.48
SLC22A16 Q86VW1 1/20 0.42
SLC7A5 Q01650 1/20 0.41
GRIK1 P39086 8/20 0.40
GRIK2 Q13002 5/20 0.40
GRM1 Q13255 2/20 0.38
GRM2 Q14416 2/20 0.38
GRIA4 P48058 4/20 0.38
GRIK3 Q13003 4/20 0.38
GRIK5 Q16478 4/20 0.38
SLC1A3 P43003 4/20 0.37
SLC1A2 P43004 4/20 0.37
SLC1A1 P43005 3/20 0.37
GRIA2 P42262 3/20 0.37
GRIA1 P42261 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspartic Acid SCHEMBL379368 0.85 CPT2 (0.44) TSHRALDH1A1LMNAAPEX1CPT2
Aspartic Acid SCHEMBL1302396 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2
Aspartic Acid SCHEMBL1301554 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2
Aspartic Acid SCHEMBL1301523 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2
Aspartic Acid SCHEMBL7703371 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2
Aspartic Acid SCHEMBL9293073 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2
Aspartic Acid SCHEMBL1259586 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2
Aspartic Acid SCHEMBL1302394 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2
Aspartic Acid SCHEMBL1302714 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2
Aspartic Acid SCHEMBL1301891 0.80 GRIK1 (0.50) SLC7A5GRIK1GRIK2GRM1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059904-A1 SUPRAMOLECULAR ASSEMBLIES AND COMPOSITIONS COMPRISING THE SAME ELC MANAGEMENT LLC (US) 2025-03-27 WO claimed
US-20250332081-A1 A Composition Against Osmotic Stress ELC MAN LLC (US) 2025-10-30 US disclosed
WO-2025059904-A1 SUPRAMOLECULAR ASSEMBLIES AND COMPOSITIONS COMPRISING THE SAME ELC MANAGEMENT LLC (US) 2025-03-27 WO disclosed
EP-4469023-A1 A COMPOSITION AGAINST OSMOTIC STRESS ELC Management LLC (US) 2024-12-04 EP disclosed
WO-2023141799-A1 A COMPOSITION AGAINST OSMOTIC STRESS ELC MANAGEMENT LLC (US) 2023-08-03 WO disclosed
US-20160287658-A1 COMPOSITION FOR MOISTURIZING SKIN AMOREPACIFIC CORPORATION (KR) 2016-10-06 US disclosed
EP-2408315-B1 A METHOD OF REDUCING THE RATE OF DEGRADATION OF A BIOLOGICAL MATERIAL BIO ENERGY INGREDIENTS LTD (GB) 2014-12-10 EP disclosed
EP-2633762-A1 A method of reducing the rate of degradation of a biological material Bio-Energy Ingredients Limited (GB) 2013-09-04 EP disclosed
CN-102524703-A Betaine natural vegetable and fruit powder and preparation method thereof BEIJING FUYOU LONGHUI BIO TECHNOLOGY CO LTD 2012-07-04 CN disclosed
EP-2408315-A2 A METHOD OF REDUCING THE RATE OF DEGRADATION OF A BIOLOGICAL MATERIAL Bio-Energy Ingredients Limited (GB) 2012-01-25 EP disclosed
US-20120009280-A1 METHOD OF REDUCING THE RATE OF DEGRADATION OF A BIOLOGICAL MATERIAL BIO-ENERGY INGREDIENTS LIMITED (GB) 2012-01-12 US disclosed
WO-2010106475-A2 A METHOD OF REDUCING THE RATE OF DEGRADATION OF A BIOLOGICAL MATERIAL BIO-ENERGY INGREDIENTS LIMITED (GB) 2010-09-23 WO disclosed
US-6354965-B1 Golf balls including low water activity fluid and methods for making same ACUSHNET COMPANY 2002-03-12 US disclosed
US-4703045-A BETAINE SALTS SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (FR) 1987-10-27 US disclosed
US-4593020-A Betaine citrate SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (FR) 1986-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250332081-A1 A Composition Against Osmotic Stress CUTA, SLC6A12, LBR TSHR 3037/4885ALDH1A1 3858/4885LMNA 962/4885
US-20120009280-A1 METHOD OF REDUCING THE RATE OF DEGRADATION OF A BIOLOGICAL MATERIAL PIGS, CD68, GYS1 TSHR 3180/4885ALDH1A1 4608/4885LMNA 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.